Long list of conflicts of interest in industry-funded drug trials are counterproductive and opaque for readers

IF 7.3 2区医学 Q1 HEALTH CARE SCIENCES & SERVICES Journal of Clinical Epidemiology Pub Date : 2024-10-01 DOI:10.1016/j.jclinepi.2024.111491

Sophie Leducq, Richard Barlow, Arabella Baker, Mikolaj Swiderski, Hywel C. Williams

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

由企业资助的药物试验中存在的一长串利益冲突会适得其反，而且对读者来说也不透明。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Clinical Epidemiology 医学-公共卫生、环境卫生与职业卫生

CiteScore

12.00

自引率

6.90%

发文量

320

审稿时长

44 days

期刊介绍： The Journal of Clinical Epidemiology strives to enhance the quality of clinical and patient-oriented healthcare research by advancing and applying innovative methods in conducting, presenting, synthesizing, disseminating, and translating research results into optimal clinical practice. Special emphasis is placed on training new generations of scientists and clinical practice leaders.

期刊最新文献

Research culture influences in health and biomedical research: Rapid scoping review and content analysis. Corrigendum to 'Avoiding searching for outcomes called for additional search strategies: a study of cochrane review searches' [Journal of Clinical Epidemiology, 149 (2022) 83-88]. A methodological review identified several options for utilizing registries for randomized controlled trials. Real-time Adaptive Randomization of Clinical Trials. Some superiority trials with non-significant results published in high impact factor journals correspond to non-inferiority situations: a research-on-research study.